Gallego et al., 2001 - Google Patents
Prolactin, growth hormone, and epidermal growth factor activate Stat5 in different compartments of mammary tissue and exert different and overlapping developmental …Gallego et al., 2001
View PDF- Document ID
- 11327259362144542921
- Author
- Gallego M
- Binart N
- Robinson G
- Okagaki R
- Coschigano K
- Perry J
- Kopchick J
- Oka T
- Kelly P
- Hennighausen L
- Publication year
- Publication venue
- Developmental biology
External Links
Snippet
Prolactin (Prl)-induced phosphorylation of Stat (signal transducer and activator of transcription) 5 is considered a key event in functional mammary development and differentiation. We now demonstrate that not only Prl, but also growth hormone (GH) and …
- 102100008842 GH1 0 title abstract description 63
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/82—Translation products from oncogenes
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Gallego et al. | Prolactin, growth hormone, and epidermal growth factor activate Stat5 in different compartments of mammary tissue and exert different and overlapping developmental effects | |
| Lin et al. | Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy | |
| Brisken et al. | IGF-2 is a mediator of prolactin-induced morphogenesis in the breast | |
| Long et al. | Impaired differentiation and lactational failure of Erbb4-deficient mammary glands identify ERBB4 as an obligate mediator of STAT5 | |
| Hennighausen et al. | Think globally, act locally: the making of a mouse mammary gland | |
| Robinson et al. | The C/EBPβ transcription factor regulates epithelial cell proliferation and differentiation in the mammary gland | |
| Wagner et al. | Jak2/Stat5 signaling in mammogenesis, breast cancer initiation and progression | |
| Vonderhaar | Prolactin involvement in breast cancer. | |
| Pangas et al. | Intraovarian activins are required for female fertility | |
| Zhao et al. | Mice without a functional relaxin gene are unable to deliver milk to their pups | |
| Webster et al. | Induction of mammary epithelial hyperplasias and mammary tumors in transgenic mice expressing a murine mammary tumor virus/activated c-src fusion gene. | |
| Van Roeyen et al. | Induction of progressive glomerulonephritis by podocyte-specific overexpression of platelet-derived growth factor-D | |
| Binart et al. | A short form of the prolactin (PRL) receptor is able to rescue mammopoiesis in heterozygous PRL receptor mice | |
| Zhang et al. | Overexpression of transcription factor AP-2α suppresses mammary gland growth and morphogenesis | |
| Lim et al. | Differential expression of the erb B2 gene in the periimplantation mouse uterus: Potential mediator of signaling by epidermal growth factor-like growth factors | |
| Le et al. | Generation of mice expressing only the long form of the prolactin receptor reveals that both isoforms of the receptor are required for normal ovarian function | |
| Boelaert et al. | A potential role for PTTG/securin in the developing human fetal brain | |
| Banks et al. | The prolactin receptor: A cross‐species comparison of gene structure, transcriptional regulation, tissue‐specificity, and genetic variation | |
| Muñiz et al. | Hyper-ovulation in an ovarian-specific transgenic mouse model | |
| Hadsell | The insulin-like growth factor system in normal mammary gland function | |
| WO2005120547A1 (en) | Use of neuregulin-3 for inducing mammary cell differentiation and for the treatment of breast cancer | |
| Cuttitta et al. | The role of adrenomedullin as a growth regulatory peptide in the normal and malignant setting | |
| US20100150930A1 (en) | Mage-11 as a marker for endometrial receptivity to embryo transplantation and a marker and therapeutic target in castration-recurrent prostate cancer | |
| Khan et al. | Protooncogenes and growth factors in steroid hormone induced growth and differentiation | |
| Schomberg | Growth factors in reproduction |